As per the independent prognostic and survival analyses, few of the important differentially expressed genes, including MRC1, CP, ITGA5, SNCA, HARS1, ENPP1, and PLAU may function as potent biomarkers for screening and characterizing different stages of CHOL patients with COVID-19. This evidence concerns the gene HARS1 and COVID-19.